Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2025-07-01
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise with Low Frequency
Low Frequency
396 Hertz (Hz), 417 Hz, 528 Hz, 639 Hz
Exercise with High Frequency
High Frequency Music
741 Hz, 852 Hz, 963 Hz
Exercise without Music
Exercise
Exercise without music
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Exercise without music
Low Frequency
396 Hertz (Hz), 417 Hz, 528 Hz, 639 Hz
High Frequency Music
741 Hz, 852 Hz, 963 Hz
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not having any ongoing musculoskeletal problems that prevent doing exercise/physical activity (Will be assessed with the Physical ActivityReadiness Questionnaire).
* Being physically inactive according to the International Physical Activity Short Form
* Being a volunteer to participate in the study.
* Being able to read and understand Turkish.
Exclusion Criteria
* Having any hearing problems or colorblindness,
* Using regular medications with potential neurological side effects (psychiatric medications, painkillers, etc.).
* Continuing treatment due to a psychiatric diagnosis such as clinical depression, anxiety, bipolar disorder, or schizophrenia.
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Scientific and Technological Research Council of Turkey
OTHER
Biruni University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Begum Kara Kaya
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Begüm Kara Kaya, PhD
Role: PRINCIPAL_INVESTIGATOR
Biruni University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biruni University
Zeytinburnu, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025
Identifier Type: -
Identifier Source: org_study_id